Novo Nordisk ٣٠ أبريل ٢٠٢٦ Is Novo Nordisk's GLP-1 dominance fading after Lilly's clinical wins? - MSN
Novo Nordisk ٢٩ أبريل ٢٠٢٦ Canada Approves Dr. Reddy’s Generic Version of Novo Nordisk’s Ozempic - WSJ
Novo Nordisk ٢٩ أبريل ٢٠٢٦ Novo Nordisk faces competition from Canadian generic version of Ozempic - medwatch.com
Novo Nordisk ٢٨ أبريل ٢٠٢٦ Novo Holdings makes 1st commitment to Korean PEF as global pharma capital targets K-bio - KED Global
Novo Nordisk ٢٧ أبريل ٢٠٢٦ The 10 Most Influential Health and Life Science Companies of 2026 - Time Magazine
Novo Nordisk ٢٣ أبريل ٢٠٢٦ With trial win, Novo Nordisk eyes adolescent diabetes approval for oral semaglutide - Fierce Pharma
Novo Nordisk ٢٠ أبريل ٢٠٢٦ Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory - Yahoo
Novo Nordisk ٢٠ أبريل ٢٠٢٦ Novo Nordisk Details Progress of DKK 15 Billion Share Buyback Programme - TipRanks
Novo Nordisk ٢٠ أبريل ٢٠٢٦ Novo readies SCD drug from $1.1B Forma buyout for approval push after phase 3 win - Fierce Biotech
Novo Nordisk ٢٠ أبريل ٢٠٢٦ Novo posts trial win for sickle cell disease drug (NVO:NYSE) - Seeking Alpha
Novo Nordisk ٢٠ أبريل ٢٠٢٦ Novo Nordisk to seek oral sickle cell therapy approval after Phase III victory - Clinical Trials Arena
Novo Nordisk ١٧ أبريل ٢٠٢٦ Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied. - Investor's Business Daily